For example, TRIM24 was able to boost the ER, AR, and STAT3 pathways in breast, prostate and brain cancers, respectively [128,129,130], in addition to targeting wtp53 for degradation in breast cancer [94]. This evidence concerns the gene TRIM24 and breast carcinoma.